Aceragen, Inc. – NASDAQ:ACGN
Aceragen stock price monthly change
Aceragen stock price quarterly change
Aceragen key metrics
Market Cap | 3.24M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAceragen stock price history
Aceragen stock forecast
Aceragen financial statements
| Jun 2022 | 0 | -5.30M | |
|---|---|---|---|
| Sep 2022 | 49K | -3.09M | -6324.49% |
| Dec 2022 | 4.81M | -10.77M | -223.89% |
| Mar 2023 | 0 | 0 |
| Mar 2022 | 30133000 | 4.29M | 14.24% |
|---|---|---|---|
| Jun 2022 | 26306000 | 5.17M | 19.67% |
| Sep 2022 | 103682000 | 82.91M | 79.97% |
| Dec 2022 | 101107000 | 62.17M | 61.49% |
| Mar 2022 | -4.56M | 0 | 16K |
|---|---|---|---|
| Jun 2022 | -3.52M | 0 | 12K |
| Sep 2022 | -3.19M | 5.48M | 31K |
| Dec 2022 | -13.20M | 0 | -1.54M |
Aceragen alternative data
| Aug 2023 | 26 |
|---|---|
| Sep 2023 | 26 |
| Oct 2023 | 26 |
| Nov 2023 | 26 |
| Dec 2023 | 26 |
| Jan 2024 | 26 |
| Feb 2024 | 26 |
| Mar 2024 | 26 |
| Apr 2024 | 26 |
| May 2024 | 26 |
| Jun 2024 | 26 |
| Jul 2024 | 26 |
Aceragen other data
Thursday, 26 December 2024 | ||
| MoonFox Analysis | "ACGN Merch Economy" Surge and the Breakthrough of the "Dimension Wall" in ACGN Consumption | prnewswire.com |
-
When is Aceragen's next earnings date?
Unfortunately, Aceragen's (ACGN) next earnings date is currently unknown.
-
Does Aceragen pay dividends?
No, Aceragen does not pay dividends.
-
How much money does Aceragen make?
Aceragen has a market capitalization of 3.24M.
-
What is Aceragen's stock symbol?
Aceragen, Inc. is traded on the NASDAQ under the ticker symbol "ACGN".
-
What is Aceragen's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Aceragen?
Shares of Aceragen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Aceragen have?
As Jul 2024, Aceragen employs 26 workers.
-
When Aceragen went public?
Aceragen, Inc. is publicly traded company for more then 29 years since IPO on 25 Jan 1996.
-
What is Aceragen's official website?
The official website for Aceragen is aceragen.com.
-
Where are Aceragen's headquarters?
Aceragen is headquartered at 505 Eagleview Boulevard, Exton, PA.
-
How can i contact Aceragen?
Aceragen's mailing address is 505 Eagleview Boulevard, Exton, PA and company can be reached via phone at +48 43481600.
Aceragen company profile:
Aceragen, Inc.
aceragen.comNASDAQ
26
Biotechnology
Healthcare
Aceragen, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and rheumatic diseases in the United States. Its clinical development pipeline includes ACG-701, which is in Phase 2 clinical trial for cystic fibrosis pulmonary exacerbations, as well as for melioidosis; and ACG-801 for farber disease. Aceragen, Inc. has a collaboration and option agreement with Scriptr Global, Inc. to identify, research, and develop gene therapy candidates for the treatment, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich's Ataxia. The company was formerly known as Idera Pharmaceuticals, Inc. and changed its name to Aceragen, Inc. in January 2023. Aceragen, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
Exton, PA 19341
CIK: 0000861838
:
:
